Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical factors associated with resistance to microvascular complications in diabetic patients of extreme disease duration: the 50-year medalist study.

Literature DB >> 17507696

Clinical factors associated with resistance to microvascular complications in diabetic patients of extreme disease duration: the 50-year medalist study.

Hillary A Keenan¹, Tina Costacou, Jennifer K Sun, Alessandro Doria, Jerry Cavellerano, Joseph Coney, Trevor J Orchard, Lloyd Paul Aiello, George L King.

Abstract

Entities: Disease Species

Mesh：

Year: 2007 PMID： 17507696 DOI： 10.2337/dc06-2222

Source DB: PubMed Journal: Diabetes Care ISSN： 0149-5992 Impact factor: 19.112

Keyword Cloud
Cited

× No keyword cloud information.

66 in total

1. Improvements in the lifestyle of patients who have had type 1 diabetes for 50 years: an optimistic message.

Authors: J-J Altman; C Vincent-Cassy; S Feldman-Billard
Journal: Diabetologia Date: 2008-11-26 Impact factor: 10.122

2. How to survive diabetes.

Authors: E A M Gale
Journal: Diabetologia Date: 2009-04 Impact factor: 10.122

Review 3. The role of genetics in susceptibility to diabetic retinopathy.

Authors: Gerald Liew; Ronald Klein; Tien Y Wong
Journal: Int Ophthalmol Clin Date: 2009

4. Erianin alleviates diabetic retinopathy by reducing retinal inflammation initiated by microglial cells via inhibiting hyperglycemia-mediated ERK1/2-NF-κB signaling pathway.

Authors: Tianyu Zhang; Hao Ouyang; Xiyu Mei; Bin Lu; Zengyang Yu; Kaixian Chen; Zhengtao Wang; Lili Ji
Journal: FASEB J Date: 2019-07-31 Impact factor: 5.191

Review 5. Kidney complications: factors that protect the diabetic vasculature.

Authors: Christian Rask-Madsen; George L King
Journal: Nat Med Date: 2010-01 Impact factor: 53.440

6. Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction.

Authors: Weier Qi; Hillary A Keenan; Qian Li; Atsushi Ishikado; Aimo Kannt; Thorsten Sadowski; Mark A Yorek; I-Hsien Wu; Samuel Lockhart; Lawrence J Coppey; Anja Pfenninger; Chong Wee Liew; Guifen Qiang; Alison M Burkart; Stephanie Hastings; David Pober; Christopher Cahill; Monika A Niewczas; William J Israelsen; Liane Tinsley; Isaac E Stillman; Peter S Amenta; Edward P Feener; Matthew G Vander Heiden; Robert C Stanton; George L King
Journal: Nat Med Date: 2017-04-24 Impact factor: 53.440

Clinical factors associated with resistance to microvascular complications in diabetic patients of extreme disease duration: the 50-year medalist study.

1. Improvements in the lifestyle of patients who have had type 1 diabetes for 50 years: an optimistic message.

2. How to survive diabetes.

Review 3. The role of genetics in susceptibility to diabetic retinopathy.

4. Erianin alleviates diabetic retinopathy by reducing retinal inflammation initiated by microglial cells via inhibiting hyperglycemia-mediated ERK1/2-NF-κB signaling pathway.

Review 5. Kidney complications: factors that protect the diabetic vasculature.

6. Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction.

Review 7. Implications of treatment that target protective mechanisms against diabetic nephropathy.

8. Residual insulin production and pancreatic ß-cell turnover after 50 years of diabetes: Joslin Medalist Study.

9. Betacellulin induces increased retinal vascular permeability in mice.

10. Human genetics of diabetic retinopathy: current perspectives.